A Dual Role of Cyclin E in Cell Proliferation and Apotosis May Provide a Target for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
65-75
Author(s):
S. Mazumder, E. L. DuPree and A. Almasan
Protein Kinase CK2 as Regulator of Cell Survival: Implications for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
77-84
Author(s):
G. M. Unger, A. T. Davis, J. W. Slaton and K. Ahmed
Novel Targeting of Apoptosis Pathways for Prostate Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
85-95
Author(s):
Jason B. Garrison and Natasha Kyprianou
Death Receptors as Targets of Cancer Therapeutics
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
97-104
Author(s):
M. Saeed Sheikh and Ying Huang
Author index to volume 3
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
104-105
Author(s):
Bentham Science Publishers
Subject index to volume 3
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
107-110
Author(s):
Bentham Science Publishers
Intravenous and Regional Paclitaxel Formulations
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
397-402
Author(s):
Rajendra Pawar, Ariella Shikanov, Boris Vaisman and Abraham J. Domb
Glucocorticoids Selectively Inhibit Paclitaxel-Induced Apoptosis: Mechanisms and Its Clinical Impact
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
403-411
Author(s):
Weimin Fan, Meihua Sui and Yi Huang
Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
413-424
Author(s):
Si-Shen Feng, Li Mu, Khin Yin Win and Guofeng Huang
Chronic Administration of Single Weekly Paclitaxel in Heavily Pretreated Ovarian Cancer Patients
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
425-428
Author(s):
Kenji Yamamoto, Shirei Oogi, Hiromi Inoue, Kazuya Kudoh, Tsunekazu Kita and Yoshihiro Kikuchi